Intrapericardial administration of novel DNA formulations based on thermosensitive Poloxamer 407 gel

International Journal of Pharmaceutics

Volumn 331, Issue 2, 2007, Pages 220-223

  Roques, C ^a,b   Salmon, A ^a   Fiszman, M Y ^a   Fattal, E ^b   Fromes, Y ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIV PARIS SUD   (France)

^c SAINT JOSEPH HOSPITAL   (France)

Author keywords

Gene therapy; Intrapericardial administration; Plasmid DNA; Polyethyleneimine; Thermosensitive gel

Indexed keywords

BETA GALACTOSIDASE; LUTROL; PLASMID DNA; POLOXAMER; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EVALUATION; GEL; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE VECTOR; HEART FAILURE; HEART MUSCLE; HEAT SENSITIVITY; HUMAN; INJECTION SITE; MOLECULAR SIZE; NONVIRAL GENE DELIVERY SYSTEM; POLYMERIZATION; PRIORITY JOURNAL; PROTECTION; SURFACE CHARGE; TREATMENT OUTCOME; ZETA POTENTIAL;

CARDIOMYOPATHIES; DNA; DRUG CARRIERS; GELS; INFUSIONS, PARENTERAL; PERICARDIUM; POLOXAMER; POLYETHYLENEIMINE; SURFACE-ACTIVE AGENTS; TEMPERATURE;

EID: 33846785466     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.11.056     Document Type: Article

References (21)

1. Bochot A., Fattal E., Grossiord J.L., Puisieux F., and Couvreur P. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. Int. J. Pharm. 162 (1998) 119-127
2. Boeckle S., von Gersdorff K., van der Piepen S., Culmsee C., Wagner E., and Ogris M. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J. Gene Med. 6 (2004) 1102-1111
3. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7297-7301
4. Chollet P., Favrot M.C., Hurbin A., and Coll J.L. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med. 4 (2002) 84-91
5. Demeneix B., and Behr J.-P. Polyethylenimine (PEI). In: Huang L., Hung M.-C., and Wagner E. (Eds). Advances in Genetics, vol. 53. Non-Viral Vectors for Gene Therapy. second ed. (2005), Academic Press, New York 215-230
6. Donahue J.K., Kikkawa K., Johns D.C., Marban E., and Lawrence J.H. Ultrarapid, highly efficient viral gene transfer to the heart. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4664-4668
7. Edsman K., Carlfors J., and Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci. 6 (1998) 105-112
8. Fattal E., De Rosa G., and Bochot A. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids. Int. J. Pharm. 277 (2004) 25-30
9. Fromes Y., Salmon A., Wang X., Collin H., Rouche A., Hagege A., Schwartz K., and Fiszman M.Y. Gene delivery to the myocardium by intrapericardial injection. Gene Ther. 6 (1999) 683-688
10. Godbey W.T., Wu K.K., and Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J. Control. Release 60 (1999) 149-160
11. Jones J.M., and Koch W.J. Gene therapy approaches to cardiovascular disease. Methods Mol. Med. 112 (2005) 15-35
12. Kircheis R., Wightman L., and Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev. 53 (2001) 341-358
13. Lamping K.G., Rios C.D., Chun J.A., Ooboshi H., Davidson B.L., and Heistad D.D. Intrapericardial administration of adenovirus for gene transfer. Am. J. Physiol. 272 (1997) H310-H317
14. Logeart D., Hatem S.N., Heimburger M., Le Roux A., Michel J.B., and Mercadier J.J. How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures?. Hum. Gene Ther. 12 (2001) 1601-1610
15. Lungwitz U., Breunig M., Blunk T., and Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60 (2005) 247-266
16. Nayak, and Rosengart. Gene therapy for heart failure. Semin. Thoracic Cardiovascular Surg. 17 (2005) 343-347
17. Ogris M., Steinlein P., Kursa M., Mechtler K., Kircheis R., and Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 5 (1998) 1425-1433
18. Quarck R., and Holvoet P. Gene therapy approaches for cardiovascular diseases. Curr. Gene Ther. 4 (2004) 207-223
19. Regnstrom K., Ragnarsson E.G., Koping-Hoggard M., Torstensson E., Nyblom H., and Artursson P. PEI-a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice. Gene Ther. 10 (2003) 1575-1583
20. Schmolka I.R. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. 6 (1972) 571-582
21. Sun Z. Overview of recent advances in molecular cardiology. Can. J. Cardiol. 22 (2006) 235-240